000 01874 a2200529 4500
005 20250511014504.0
264 0 _c19790626
008 197906s 0 0 eng d
022 _a0098-7484
024 7 _a10.1001/jama.241.17.1813
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohen, M H
245 0 0 _aThymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
_h[electronic resource]
260 _bJAMA
_cApr 1979
300 _a1813-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Small Cell
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEtoposide
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadministration & dosage
650 0 4 _aLomustine
_xadministration & dosage
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aProcarbazine
_xadministration & dosage
650 0 4 _aThymosin
_xadministration & dosage
650 0 4 _aThymus Hormones
_xadministration & dosage
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aChretien, P B
700 1 _aIhde, D C
700 1 _aFossieck, B E
700 1 _aMakuch, R
700 1 _aBunn, P A
700 1 _aJohnston, A V
700 1 _aShackney, S E
700 1 _aMatthews, M J
700 1 _aLipson, S D
700 1 _aKenady, D E
700 1 _aMinna, J D
773 0 _tJAMA
_gvol. 241
_gno. 17
_gp. 1813-5
856 4 0 _uhttps://doi.org/10.1001/jama.241.17.1813
_zAvailable from publisher's website
999 _c214721
_d214721